OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection
Hans Verkerke, Gregory L. Damhorst, Daniel S. Graciaa, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 9, pp. 1577-1587
Open Access | Times Cited: 18

Showing 18 citing articles:

Blood group A enhances SARS-CoV-2 infection
Shang‐Chuen Wu, Connie M. Arthur, Hau-Ming Jan, et al.
Blood (2023) Vol. 142, Iss. 8, pp. 742-747
Open Access | Times Cited: 29

ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies
Ryan Philip Jajosky, Shang‐Chuen Wu, Léon Zheng, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105798-105798
Open Access | Times Cited: 35

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
Kanal Singh, Kevin Rubenstein, Viviane Callier, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. 624-634
Open Access | Times Cited: 4

Prevalence and clinical relevance of viraemia in viral respiratory tract infections: a systematic review
Karl Hagman, Tamara Postigo, David Diez-Castro, et al.
The Lancet Microbe (2024), pp. 100967-100967
Open Access | Times Cited: 4

SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
Nicolas Capelli, Léa Domitien Payet, Carmen Alcocer Cordellat, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2

Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
Gregory L. Damhorst, Nils Schoof, Phuong-Vi Nguyen, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 5

Viral, Immunologic, and Laboratory Parameters in Patients With and Without Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Sang Hyun, Euijin Chang, Ji‐Soo Kwon, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 35
Open Access | Times Cited: 1

ABO blood groups and galectins: Implications in transfusion medicine and innate immunity
Connie M. Arthur, Marie A. Hollenhorst, Shang‐Chuen Wu, et al.
Seminars in Immunology (2024) Vol. 74-75, pp. 101892-101892
Closed Access | Times Cited: 1

Impaired systemic nucleocapsid antigen clearance in severe COVID‐19
Christian Bauer, Elisabeth Mack, Véronique Hefter, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 3

Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19
Eli Wilber, Anne Piantadosi, Ahmed Babiker, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 8
Open Access | Times Cited: 4

SARS-CoV-2 Antigenemia is Associated With Pneumonia in Children But Lacks Sensitivity to Diagnose Acute Infection
Gregory L. Damhorst, Hans Verkerke, Kristin R V Harrington, et al.
The Pediatric Infectious Disease Journal (2022) Vol. 42, Iss. 2, pp. 130-135
Open Access | Times Cited: 4

Comparative analysis of eleven SARS-CoV-2 immunoassays and neutralisation data: time to enhance standardisation and correlation of protection
Jorge-Julio Cabrera-Alvargonzalez, Carlos Daviña Núñez, Sonia Rey Cao, et al.
Infectious Diseases (2024) Vol. 56, Iss. 12, pp. 1067-1079
Open Access

Diagnostic utility of SARS-CoV-2 nucleocapsid antigenemia: a meta-analysis
Gregory L. Damhorst, Sydney E Martin, Eli Wilber, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 10
Open Access

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021
Daniel S. Graciaa, Hans Verkerke, Jeannette Guarner, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 2

Impaired systemic nucleocapsid antigen clearance in severe COVID-19
Christian Keller, Christian Bauer, Elisabeth Mack, et al.
Authorea (Authorea) (2023)
Open Access

Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
Xihong Zhang, Chungen Qian, Li Yang, et al.
PeerJ (2023) Vol. 11, pp. e15515-e15515
Open Access

Page 1

Scroll to top